Table 3.
Full model |
SGM model |
|||
---|---|---|---|---|
n = 377 |
n = 257 |
|||
Participant characteristics | AOR | (95% CI) | AOR | (95% CI) |
| ||||
Gender identity | ||||
Cisgender male | Reference | Reference | ||
Cisgender female | 0.31*** | [0.18–0.53] | 0.22*** | (0.11–0.43) |
Transgender malea | – | – | – | – |
Transgender female | 1.3 | (0.26–6.3) | 0.21 | (0.03–1.4] |
Sexual orientation | ||||
Heterosexual | Reference | – | – | |
Gay/lesbian | 3.1** | (1.5–6.3) | Reference | |
Bisexual/other | 2.8** | (1.4–5.8) | 1.4 | (0.67–2.9) |
Health insurance | ||||
Yes | 0.31** | (0.14–0.72) | ||
No | Reference | |||
Bad experiences in health care | ||||
Yes | 3.5*** | (2.0–6.0) | 5.6*** | (2.5–12.7) |
No | Reference | Reference | ||
Victimization scoreb | 1.3*** | (1.1–1.5) |
Note. Psuedo R2: Full model = 21.3%, SGM model = 33.4%. Both models had “good fit” according to the Hosmer–Lemeshow test (p > .0.05). AOR = adjusted odds ratio; PHQ-2 = Patient Health Questionnaire 2; SGM = sexual and gender minorities; CI = confidence interval.
AOR for transgender males not estimated as all screened positive for depression.
Victimization score only included in SGM model.
For a two-tailed test:
indicates p < .05.
indicates p < .01, and
indicates p < .001.